Maggenome Technologies Private Limited - Due diligence report
A 360° intelligence report on Maggenome: trust score, financial health, credit view, compliance, directors, growth and distress signals - ge…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Maggenome — 360° Intelligence Report
Generated from MCA filings & public recordsMaggenome is assessed as Moderate with a Trust Score of 71/100. Maggenome is an active private limited indian non-government company incorporated in 2015, operating in the Life Sciences sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Maggenome Technologies Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- 2 active GST registration(s).
Director Intelligence
Stability score: 80/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| BALAMANIAMMA MADATHINKAL RAGHAVAN NAIR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHANIYILPARAMPU NANAPPAN RAMCHAND | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Jegatheesan Mohan | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- 4 director exits in 3 years - high churn.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2023 annual returnPromoters hold the largest single block of equity - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 70 · Distress 50Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Chopra Chemstab Private Limited | U24299DL2020PTC367585 | Delhi, Delhi, India |
| Vasuki Colour Anodise Private Limited | U24220GJ2012PTC069021 | Rajkot, Gujarat, India |
| Ranke Atharva Enterprise Private Limited | U74900GJ2007PTC052223 | Ankleshwar, Gujarat, India |
| Blossoms Aroma Private Limited | U24111DL2006PTC148704 | New Delhi, Delhi, India |
| Von Chem Private Limited | U24100MH2020PTC343551 | Thane, Maharashtra, India |
| Achemic Pharmaceuticals (India) Private Limited | U51397BR1985PTC002216 | Patna, Bihar, India |
| Creative Remedies Pvt Ltd | U24231GJ1989PTC012151 | Ahmedabad, Gujarat, India |
| Malhar Pharmatech Private Limited | U33309MH2020PTC349534 | Thane, Maharashtra, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Maggenome before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Maggenome: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Maggenome - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 71/100, distress signals and MSME payment-delay disclosures - know whether Maggenome pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Maggenome - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Maggenome an active company?
Maggenome has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Maggenome financially healthy?
Maggenome has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Maggenome?
Its overall Trust Score is 71/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Maggenome?
Promoters hold the largest single block of equity - exact percentages are in the full report. 3 active director(s) are on record.
Does Maggenome have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Maggenome up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Maggenome?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.